M3DLoC | Additive Manufacturing of 3D Microfluidic MEMS for Lab-on-a-Chip applications

Summary
MEDLOC aims at the employment of multi-material 3D printing technologies for the large-scale fabrication of microfluidic MEMS for lab-on-a-chip and sensing applications. The concept is based on the combination of multimaterial direct-ink-writing method and an extrusion-based 3D printing pilot line, in order to fabricate microstructured detection devices with the ability to perform all steps of chemical analysis in an automated fashion. The functionality of these devices will be evaluated based on their ability to streamline all steps needed to obtain mobility and binding-based identity information in one continuous biochemical detection system. Optimum in-line control systems will be incorporated in various stages of the fabrication process, to achieve precise control and repeatability. Microfluidic MEMS are increasingly recognized as a unique technology field for the development of biomedical devices (BioMEMS), due to their functional performance on the microscale, at the dimensions of which most physiological processes are operative. Applications near micro- and nanoscale are promising in the field of intelligent biosensors, where it enables the monolithic integration of sensing devices with intelligent functions like molecular detection, signal analysis, electrical stimulation, data transmission, etc., in a single microchip.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/760662
Start date: 01-01-2018
End date: 30-06-2022
Total budget - Public funding: 9 610 849,00 Euro - 7 924 157,00 Euro
Cordis data

Original description

MEDLOC aims at the employment of multi-material 3D printing technologies for the large-scale fabrication of microfluidic MEMS for lab-on-a-chip and sensing applications. The concept is based on the combination of multimaterial direct-ink-writing method and an extrusion-based 3D printing pilot line, in order to fabricate microstructured detection devices with the ability to perform all steps of chemical analysis in an automated fashion. The functionality of these devices will be evaluated based on their ability to streamline all steps needed to obtain mobility and binding-based identity information in one continuous biochemical detection system. Optimum in-line control systems will be incorporated in various stages of the fabrication process, to achieve precise control and repeatability. Microfluidic MEMS are increasingly recognized as a unique technology field for the development of biomedical devices (BioMEMS), due to their functional performance on the microscale, at the dimensions of which most physiological processes are operative. Applications near micro- and nanoscale are promising in the field of intelligent biosensors, where it enables the monolithic integration of sensing devices with intelligent functions like molecular detection, signal analysis, electrical stimulation, data transmission, etc., in a single microchip.

Status

CLOSED

Call topic

PILOTS-04-2017

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
H2020-EU.2.1.2.0. INDUSTRIAL LEADERSHIP - Nanotechnologies - Cross-cutting call topics
H2020-NMBP-PILOTS-2017
PILOTS-04-2017 Pilot Lines for 3D printed and/or injection moulded polymeric or ceramic microfluidic MEMS